Pages that link to "Q36924379"

The following pages link to The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin (Q36924379):

Displaying 17 items.

• The Liver Circadian Clock Modulates Biochemical and Physiological Responses to Metformin (Q38620481) (← links)
• Metabolomic and Genome-wide Association Studies Reveal Potential Endogenous Biomarkers for OATP1B1. (Q38838835) (← links)
• Renal Drug Transporters and Drug Interactions (Q39140289) (← links)
• Emerging Clinical Importance of Hepatic Organic Cation Transporter 1 (OCT1) in Drug Pharmacokinetics, Dynamics, Pharmacogenetic Variability, and Drug Interactions (Q46150116) (← links)
• Transporters Involved in Metformin Pharmacokinetics and Treatment Response (Q46582714) (← links)
• Indinavir Alters the Pharmacokinetics of Lamivudine Partially via Inhibition of Multidrug and Toxin Extrusion Protein 1 (MATE1). (Q47230742) (← links)
• Beyond drug-drug interactions: effects of transporter inhibition on endobiotics, nutrients and toxins (Q47895958) (← links)
• Drug Interactions of Metformin Involving Drug Transporter Proteins (Q49332545) (← links)
• Physiologically Based Pharmacokinetic Modeling of Drug Transporters to Facilitate Individualized Dose Prediction (Q50660932) (← links)
• Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance (Q57112262) (← links)
• Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter Consortium (Q57786888) (← links)
• OCT3 promoter haplotype is associated with metformin pharmacokinetics in Koreans (Q59340008) (← links)
• ITC Commentary on Metformin Clinical Drug-Drug Interaction Study Design That Enables an Efficacy- and Safety-Based Dose Adjustment Decision (Q88675304) (← links)
• Fampridine is a Substrate and Inhibitor of Human OCT2, but not of Human MATE1, or MATE2K (Q89146031) (← links)
• Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches (Q90609524) (← links)
• No Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects (Q90863550) (← links)
• Clinical Aspects of Transporter-Mediated Drug-Drug Interactions (Q91069615) (← links)